Jeffrey Chodakewitz has an estimated net worth of $51.4 Million. This is based on reported shares across multiple companies, which include VERTEX PHARMACEUTICALS INC / MA, TETRAPHASE PHARMACEUTICALS INC, Praxis Precision Medicines, Inc., Adicet Bio, Inc., and Schrodinger, Inc..

2017 was Jeffrey Chodakewitz's most active year for acquiring shares with 20 total transactions. Jeffrey Chodakewitz's most active month to acquire stocks was the month of May. 2017 was Jeffrey Chodakewitz's most active year for disposing of shares, totalling 63 transactions. Jeffrey Chodakewitz's most active month to dispose stocks was the month of January. 2017 saw Jeffrey Chodakewitz paying a total of $9,564,653.92 for 156,227 shares, this is the most they've acquired in one year. In 2017 Jeffrey Chodakewitz cashed out on 278,999 shares for a total of $24,806,133.48, their largest year based on trade value.